Incannex Healthcare Inc.

About Incannex Healthcare Inc.

Incannex Healthcare is a science-led combination medicines company focused on developing novel oral fixed-dose treatments and therapeutic regimens for people with chronic conditions such as obstructive sleep apnea, rheumatoid arthritis, and generalized anxiety disorder.

Products & Services

IHL-42X:An oral fixed-dose combination of dronabinol and acetazolamide for obstructive sleep apnea (OSA), targeting intermittent hypoxia and hypercapnia. Currently in Phase 2/3 trials with dosing started in May 2024.

IHL-675A:An oral fixed-dose combination of cannabidiol and hydroxychloroquine sulfate for rheumatoid arthritis, aimed at reducing inflammation. Phase 2 dosing started in January 2024.

PSX-001:An oral synthetic psilocybin drug candidate for generalized anxiety disorder (GAD), administered with psychotherapy. Phase 2 trials ongoing with dosing completed for PsiGAD1 in January 2024.

IHL-42X (obstructive sleep apnea)

IHL-675A (rheumatoid arthritis)

PSX-001 (generalized anxiety disorder)

Specialties

Combination Medicines Oral Fixed-Dose Treatments Chronic Conditions Obstructive Sleep Apnea Rheumatoid Arthritis Generalized Anxiety Disorder Synthetic Cannabinoids Psilocybin Therapy combination therapies clinical trials

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 10000000 MR: - FA: 10 Million FAN: 10000000	D: 2026-03-12 FD: 2026-03-12	1 investors
2	RT: At-The-Market (ATM) Offering T: - FT: At-The-Market (ATM) Offering	A: 100000000 MR: - FA: $100 million FAN: 100000000	D: 2025-07-24 FD: 2025-07-24	2 investors
3	RT: ATM T: - FT: ATM	A: 12200000 MR: - FA: 12.2 million FAN: 12200000	D: 2025-06-12 FD: 2025-06-12	-
4	RT: At-the-Market Facility T: - FT: At-the-Market Facility	A: 16700000 MR: - FA: 16.7M FAN: 16700000	D: 2025-05-20 FD: 2025-05-20	-
5	RT: At-the-Market (ATM) Offering T: - FT: At-the-Market (ATM) Offering	A: 12500000 MR: - FA: $12.5M FAN: 12500000	D: 2025-05-20 FD: 2025-05-20	1 investors
6	RT: Private Placement T: - FT: Private Placement	A: 12500000 MR: - FA: 12.5 million FAN: 12500000	D: 2025-03-07 FD: 2025-03-07	1 investors
7	RT: Convertible Note and Equity Line of Credit T: - FT: Convertible Note and Equity Line of Credit	A: 60000000 MR: - FA: Up to 60,000,000 USD FAN: 60000000	D: 2024-09-10 FD: 2024-09-10	2 investors
8	RT: Convertible Notes and Equity Line of Credit T: - FT: Convertible Notes and Equity Line of Credit	A: 60000000 MR: - FA: $60 million FAN: 60000000	D: 2024-09-10 FD: 2024-09-10	2 investors
9	RT: Convertible Debt and Equity Line of Credit T: - FT: Convertible Debt and Equity Line of Credit	A: 60000000 MR: - FA: 60,000,000 USD FAN: 60000000	D: 2024-09-10 FD: 2024-09-10	2 investors
10	RT: Convertible Debt and Line of Credit T: - FT: Convertible Debt and Line of Credit	A: 60000000 MR: - FA: up to 60 million USD FAN: 60000000	D: 2024-09-10 FD: 2024-09-10	2 investors
11	RT: Convertible Notes and Equity Line of Credit (ELOC) T: - FT: Convertible Notes and Equity Line of Credit (ELOC)	A: 60000000 MR: - FA: $60 million FAN: 60000000	D: 2024-09-10 FD: 2024-09-10	2 investors
12	RT: Debt and Equity Line of Credit T: - FT: Debt and Equity Line of Credit	A: 60000000 MR: - FA: up to $60 million FAN: 60000000	D: 2024-09-10 FD: 2024-09-10	2 investors
13	RT: Debt T: - FT: Debt	A: 60000000 MR: - FA: 60 million FAN: 60000000	D: 2024-09-10 FD: 2024-09-10	2 investors
14	RT: Debt and Equity Financing T: - FT: Debt and Equity Financing	A: 60000000 MR: - FA: 60 million dollars FAN: 60000000	D: 2024-09-10 FD: 2024-09-10	2 investors

Registered Direct Offering Latest

2026-03-12

$10.0M

1 investor (Pro only)

At-The-Market (ATM) Offering 2025-07-24

$100.0M

ATM 2025-06-12

$12.2M

View 13 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alison Wimms

D

Douglas B. Kirsch

N

Nancy Collop

S

Scott A. Sands

C

Charlene E. Gamaldo

R

Roger S. McIntyre

View 20 more team members with Pro

Unlock Full Team Directory

Recent News